Perceptive

Perceptive is a global technology-enabled service provider for preclinical and clinical trial imaging and for Interactive Response Technology (IRT) and Randomized Trial Supply Management (RTSM). Founded in 2024, the company serves pharmaceutical, biotech and clinical research organisations across the full R&D lifecycle, from first-in-human imaging through to regulatory submission. Its teams draw on more than 50 years of combined specialised experience in clinical research, and the company reports supporting nearly 12,000 clinical trials and more than 800 regulatory approvals.

The business is organised into three units. Perceptive Discovery provides preclinical and translational imaging services, including radiochemistry and in vivo imaging. Perceptive Imaging operates as an independent imaging core laboratory for clinical trials worldwide. Perceptive eClinical supplies cloud-based randomisation and trial supply management platforms, along with electronic clinical outcome assessments (eCOA).

Technical work spans preclinical, translational and in vivo imaging, radiochemistry, clinical trial imaging and imaging core laboratory services, cloud-based randomisation, eCOA and clinical trial supply management. Therapeutic areas of focus include oncology, neuroscience, radiopharmaceutical therapy and rare diseases. Perceptive maintains a presence in the US, Europe, the UK and Asia, and operates 24/7 service delivery.

The company reports serving most of the world's leading pharmaceutical and biotech companies, and embeds clinical and imaging centres at academic institutions including Imperial College London and Barts Cancer Institute.